Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of Animal Health International, Inc. (“Animal Health” or the “Company”) (Nasdaq - AHII) relating to the proposed acquisition by Lextron, Inc. (“Lextron”). Under the terms of the transaction, Animal Health shareholders would receive $4.25 in cash for each share of common stock they own. The investigation concerns possible breaches of fiduciary duty and other violations of state law by the Board of Directors of Animal Health by not acting in Animal Health shareholders' best interests in connection with the sale process to Lextron. The transaction may undervalue Animal Health as it represents only a very small premium from where Animal Health stock has recently traded at and an analyst has set a price target of $5.00 per share on Animal Health stock. If you own shares of Animal Health stock and wish to discuss the legal ramifications of the proposed transaction, or have any questions, you may e-mail or call the law office of Brodsky & Smith, LLC who will, without obligation or cost to you, attempt to answer your questions. You may contact Jason L. Brodsky, Esquire or Evan J. Smith, Esquire at Brodsky & Smith, LLC, Two Bala Plaza, Suite 602, Bala Cynwyd, PA 19004, by e-mail at email@example.com, visiting http://brodsky-smith.com/270-ahii-animal-health-international-inc.html, or by calling toll free 877-LEGAL-90.